Don't Just Read the News, Understand It.

Published 2 days ago • loading... • Updated 2 days ago

HotSpot Therapeutics Presents Preclinical Data From Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal ...

Summary by World News

BOSTON, July 4, 2025 /PRNewswire/

13 Articles

13 Articles

All

Left

2

Center

5

Right

2

+11 Reposted by 11 other sources

HotSpot Therapeutics Presents Preclinical Data from Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal Cancers Congress 2025

BOSTON, July 4, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart Allostery platform-identified regulatory sites on proteins referred to as "natural hotspots," today announced the presentation…

2 days ago

Read Full Article

HotSpot Therapeutics Presents Preclinical Data from Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal ...

BOSTON, July 4, 2025 /PRNewswire/

2 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources13

Leaning Left2Leaning Right2Center5Last Updated12 hours agoBias Distribution

56% Center

Bias Distribution

56% of the sources are Center

56% Center

Untracked bias

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

World News broke the news in United States 2 days ago on Friday, July 4, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics